These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8145885)

  • 1. [Model of calcium oxalate lithogenesis by kinetic turbidimetry].
    Beaufays JP; Bouche R; Boistelle R
    Nephrologie; 1993; 14(6):271-81. PubMed ID: 8145885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [*calcium-oxalate lithogenesis: crystallization in the presence of urine from healthy subjects].
    Beaufays JP; Bouche R; Boistelle R
    Nephrologie; 1995; 16(4):325-31. PubMed ID: 7630471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine.
    Kavanagh JP; Jones L; Rao PN
    Clin Sci (Lond); 2000 Feb; 98(2):151-8. PubMed ID: 10657269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
    Saw NK; Chow K; Rao PN; Kavanagh JP
    J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of urinary macromolecules and chondroitin sulphate on calcium oxalate crystallization in urine.
    Rodgers AL; Ball D; Harper W
    Scanning Microsc; 1994 Mar; 8(1):71-7. PubMed ID: 7973501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary macromolecules are promoters of calcium oxalate nucleation in human urine: turbidimetric studies.
    Rodgers AL; Ball D; Harper W
    Clin Chim Acta; 1993 Nov; 220(2):125-34. PubMed ID: 8111957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation by image analysis of a turbidimetric method to study calcium oxalate crystallization.
    Hennequin C; Lalanne V; Estepa L; Drueke T; Daudon M; Lacour B
    Clin Nephrol; 1997 Nov; 48(5):292-9. PubMed ID: 9403213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glycoproteins in calcium oxalate crystal development.
    Grases F; Isern B; Perelló J; Costa-Bauzá A
    BJU Int; 2004 Jul; 94(1):177-81. PubMed ID: 15217456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid.
    Wesson JA; Worcester E
    Scanning Microsc; 1996; 10(2):415-23; 423-4. PubMed ID: 9813620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization and stone formation inside the nephron.
    Kok DJ
    Scanning Microsc; 1996; 10(2):471-84; discussion 484-6. PubMed ID: 9813625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nucleation and growth kinetics of calcium oxalate in the presence of some synthetic urine constituents.
    Rodgers AL; Garside J
    Invest Urol; 1981 May; 18(8):484-8. PubMed ID: 7228583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal growth inhibitors in human urine. Effect on calcium oxalate kinetics.
    Gardner GL; Doremus RH
    Invest Urol; 1978 May; 15(6):478-85. PubMed ID: 649298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How does bovine serum albumin prevent the formation of kidney stone? A kinetics study.
    Liu J; Jiang H; Liu XY
    J Phys Chem B; 2006 May; 110(18):9085-9. PubMed ID: 16671718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of surface active molecules on the crystallization of biominerals in solution.
    Sikirić MD; Füredi-Milhofer H
    Adv Colloid Interface Sci; 2006 Dec; 128-130():135-58. PubMed ID: 17254533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
    Kavanagh JP; Laube N
    J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
    Atmani F; Mizon J; Khan SR
    Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.